NEWS
BioSpace I MRI Data Reinforce Potential of Clene’s Nanocrystal Therapy in MS

Salt Lake City-based Clene, Inc. posted new data Monday from a Phase II trial of CNM-AU8 in multiple sclerosis featuring MRI results it claims reinforce neurological improvements originally reported in August 2022. CNM-AU8, a gold nanocrystal oral therapy, is in development to restore brain health and function by increasing production of ATP, the body’s energy currency. CNM-AU8 is […]

CFO Dive I Ratio Therapeutics CFO gets due-diligence ready

Fresh from closing a $20 million series A financing in December, biotech firm Ratio Therapeutics’ new CFO is focused on helping his young company build a sophisticated finance department. Before Reed Malleck, the company’s finance chief, arrived in October there was a part-time contract CFO, a part-time contract controller and four or five people in the company […]

MedTech Dive I Onshoring, easing labor market expected to drive double-digit growth at US medtech CDMOs

The U.S. medtech contract development and manufacturing organization (CDMO) market will grow 12.9% this year, according to a report by healthcare advisory and clinical research firm Alira Health and the Massachusetts Medical Device Industry Council (MassMEDIC). Robust fundamentals, “a steady onshoring trend of critical manufacturing processes,” and the easing of the labor market as the economic recession […]